Moderna, Inc. (MRNA)
29.34
+0.30
(+1.05%)
USD |
NASDAQ |
Dec 11, 13:42
Moderna Cash from Investing (Quarterly): 700.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.983B |
| Merck & Co., Inc. | -283.00M |
| Pfizer Inc. | -2.43B |
| Johnson & Johnson | -542.00M |
| Amgen, Inc. | -414.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -847.00M |
| Cash from Financing (Quarterly) | -1.00M |
| Free Cash Flow | -2.663B |
| Free Cash Flow Per Share (Quarterly) | -2.256 |
| Free Cash Flow to Equity (Quarterly) | -873.00M |
| Free Cash Flow to Firm (Quarterly) | -880.00M |
| Free Cash Flow Yield | -23.44% |